Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical penicillin G potassium troches for minor recurrent aphthous ulceration
ACTRN12609000499280Phase 2Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Apr 2001
- Modality
- Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Penicillin G potassium in aphthosis (RAS) and aphthous ulceration (RAS) (3 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Reduction in aphthous ulcer pain and Reduction in lesion size. Started Apr 2001; status: completed.
02
Drugs
Penicillin G potassium
03
Conditions
aphthosis (RAS)aphthous ulceration (RAS)
Beyond the preview
Go deeper on ACTRN12609000499280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000499280.